KanryAb™ Humanized Anti-Human IFN-γ mAb (Cap)

Application Scenarios & Buyer Advantages Scenario: IVD Biomarker Kit Manufacturers Local Pain Point: Unstable antigen capture performance leads to high assay CV and long antibody screening cycles for immunoassay kits. Product Advantage: Optimized for antigen immobilization & enrichment; reduces assay CV below 7.5% in sandwich assay tests, cuts antibody pairing screening time by 40%, consistent performance across 6 consecutive batches.   Scenario: CRO Bioanalysis Laboratories Local Pain Point: Poor lot-to-lot variation affects reproducibility of drug quantitation and biomarker testing. Product Advantage: Strict batch release testing with full documentation; lot-to-lot signal variation ≤5%, fully compliant with GLP requirements for bioanalytical method validation.   Scenario: Biotech R&D Institutes & Academic Labs Local Pain Point: High cost and long lead time for custom humanized antibody capture clones from overseas suppliers. Product Advantage: Ready stock of 100μg tri…